http://investorshangout.com/post/view?id=2380001

Seems like "The Real" list is getting checked off.

Also,

By the end of 2014 the Company anticipates :

Filing an orphan drug designation application with the FDA for MANF in Retinitis Pigmentosa and immediately thereafter will be submitting a second ocular orphan drug application for MANF with the FDA

http://www.thechairmansblog.com/amarantus-bio...-strength/